To the Editor, Keeping in mind our recent breakthrough in the field of biomedical effects of citrus flavanones, achieved by using an insufficiently exploited rat experimental model of old age (1,2), we consider it important to highlight the status of the antioxidative defense system in this animal model, as it is a crucial physiological definer. In general, aging represents a complex process characterized by the deterioration of overall health, slowing of the metabolism, and accumulation of numerous mutations (3). The United Nations World Population Aging Report in 2015 suggested that 12.5% of the entire human population is older than 60 years, while some demographic assessments of the World Bank predict it to reach 17% older than 65 years by 2050. Aging is associated with elevated incidences of chronic diseases, such as diabetes, hypertension, dyslipidemia, liver function disturbances, endocrine issues, osteoporosis, sarcopenia, and cancer (3,4). Changes in the antioxidant defense system (ADS), detoxification mechanisms, and cell reparation underlie the majority of the mentioned diseases (5). Namely, as a consequence of the decrease in ADS and cell reparation capacities during aging, the rate of oxidative damage increases. If reactive oxygen species (ROS) are not efficiently removed from the milieu, accumulation of oxidized and glycoxidized products can subsequently cause cellular senescence (6). It is well known that antioxidant enzymes such as superoxide dismutase (SOD) 1 and 2, catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR), as well as nonenzymatic glutathione (GSH), eliminate ROS such as superoxide anion (O 2− ) or hydrogen peroxide (H 2 O 2 ). As a consequence of the lack of their efficient removal, this can lead to damage of cellular proteins, lipids, and organelles. Oxidative metabolism in the liver causes the production of highly reactive ROS, whereby 90% of these molecules are generated in the mitochondria during the process of aerobic